You do not have access to this page
If a lesion diasapears, the measurement of that lesion is clearly 0 mm, however, if the lesion remains present, but is too small to measure accurately, a default measurement of 5 mm should be given. Unable to process the form.
Most tutorials and documentation talk much about the operations themself but very little about the sequence of operation. The database version is Your interpretation is correct although you have glossed over lines 5 - 8, but they don't add significant value to what you're saying. I don't think there are many better introductions into reading execution plans than chapter 6 in Christian Antognini's Troubleshooting Oracle Performance.
If you have the necessary licence you can use the SQL Monitor to get information on the order and the timing of the operations: And if you are interested in the optimizer's decisions of course Mr. Lewis' Cost Based Oracle would be helpful. You haven't mentioned that part in your question regarding the order of execution, but it might be worth to point out that the remaining parts of the execution plan the "and so on" in your description are all child operations of the FILTER operator - hence they could be executed as many times as there are rows produced by the first child to the FILTER operation.
Although solid lesions should be used in preference, cystic lesions may be used provided they represent the disease being studied. If a lesion diasapears, the measurement of that lesion is clearly 0 mm, however, if the lesion remains present, but is too small to measure accurately, a default measurement of 5 mm should be given. If the burden of non-target or non-measurable disease increases unequivocally, then progressive disease may be declared, but the increase really must be unequivocal.
If a new lesion appears, progressive disease is declared. If, for example, there is doubt as to whether a lesion is new or, say, inflammatory change, follow up scans are required. If the new lesion is confirmed, the date of progression is taken to be the date on which the new lesion was first detected. Complete response is the disappearance of all lesions with nodes measuring If a lesion reappears after disappearing in a patient with complete response, progressive disease is declared.
However, if such a lesion behaves in this manner in a patient with stable disease or partial response, it is the change in sum of target disease that defines the response or progression. The main specification is that imaging protocols are consistent throughout the trial.
Therefore, contrast timings, MR sequences and planes should remain the same. New response evaluation criteria in solid tumours: